Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:895370.
doi: 10.1155/2012/895370. Epub 2012 Dec 10.

Potential effects of nichi glucan as a food supplement for diabetes mellitus and hyperlipidemia: preliminary findings from the study on three patients from India

Affiliations

Potential effects of nichi glucan as a food supplement for diabetes mellitus and hyperlipidemia: preliminary findings from the study on three patients from India

Vidyasagar Devaprasad Dedeepiya et al. Case Rep Med. 2012.

Abstract

Beta Glucan food supplements have been reported to be of benefit in diabetes and hyperlipidemia. We report a pilot study of the effects of Nichi Glucan, 1, 3-1, 6 Beta Glucan food supplement, in lowering the blood glucose and lipid levels in three patients with noninsulin-dependent diabetes mellitus (NIDDM) from India. These patients had increased blood glucose and lipid levels inspite of routine antidiabetic and lipid level lowering medications. Each of the participants took 1.5 g of Nichi Glucan per day with food for two months along with their routine medications. The relevant parameters to assess glycemic status and lipid levels were calculated at the baseline and at the end of two months. After two months of continuous consumption, in one patient, the HbA1c decreased from 9.1% to 7.8%, and the glycemic target of HbA1c <6.5% laid down by the International Diabetes Federation was reached in two patients. Lipid levels also decreased significantly. Based on our findings, Nichi Glucan food supplement can be considered along with routine medications in patients with Type II diabetes with hyperlipidemia. Further studies are needed to validate the results.

PubMed Disclaimer

Figures

Figure 1
Figure 1
HbA1c Levels before and after food supplementation with Nichi Glucan.

References

    1. Anjana RM, Ali MK, Pradeepa R, et al. The need for obtaining accurate nationwide estimates of diabetes prevalence in India-rationale for a national study on diabetes. Indian Journal of Medical Research. 2011;133(4):369–380. - PMC - PubMed
    1. Pandit K, Goswami S, Ghosh S, et al. Metabolic syndrome in South Asians. Indian Journal of Endocrinology and Metabolism. 2012;16(1):44–55. - PMC - PubMed
    1. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian Journal of Medical Research. 2007;125(3):217–230. - PubMed
    1. Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nature Medicine. 2006;12(1):62–66. - PubMed
    1. Chen J, Raymond K. Beta-glucans in the treatment of diabetes and associated cardiovascular risks. Vascular Health and Risk Management. 2008;4(6):1265–1272. - PMC - PubMed

LinkOut - more resources